Koers Tibet Rhodiola Pharmaceutical Holding Co.
Aandelen
600211
CNE000000ZW7
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
47,06 CNY | -0,88% | +2,02% | -3,57% |
Omzet 2024 * | 3,44 mld. 474 mln. 443 mln. | Omzet 2025 * | 4,07 mld. 562 mln. 524 mln. | Marktkapitalisatie | 11,67 mld. 1,61 mld. 1,5 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 1,02 mld. 141 mln. 132 mln. | Nettowinst (verlies) 2025 * | 1,23 mld. 169 mln. 158 mln. | EV/omzet 2024 * | 3,39 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 2,87 x |
K/w-verhouding 2024 * |
11,4
x | K/w-verhouding 2025 * |
9,51
x | Werknemers | 601 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 37,89% |
1 dag | -0,88% | ||
1 week | +2,02% | ||
Lopende maand | +6,49% | ||
1 maand | +5,68% | ||
3 maanden | +8,86% | ||
6 maanden | +4,12% | ||
Lopend jaar | -3,57% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Yuan Dong Guo
CEO | Chief Executive Officer | 54 | - |
Jun Chen
DFI | Director of Finance/CFO | 46 | 01-01-12 |
Yu Cheng Zhou
BRD | Director/Board Member | 42 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Da Bin Chen
CHM | Chairman | 68 | - |
Yu Cheng Zhou
BRD | Director/Board Member | 42 | - |
Yuan Dong Guo
CEO | Chief Executive Officer | 54 | - |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 34 M€ | +2,22% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 47,06 | -0,88% | 2 405 300 |
24-04-24 | 47,48 | -0,57% | 3 388 089 |
23-04-24 | 47,75 | +0,67% | 3 299 580 |
22-04-24 | 47,43 | +2,48% | 4 727 190 |
19-04-24 | 46,28 | +0,33% | 2 433 800 |
slotkoers Shanghai S.E., 25 april 2024
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,57% | 1,62 mld. | |
+24,17% | 562 mld. | |
-6,33% | 358 mld. | |
+19,90% | 322 mld. | |
+7,95% | 297 mld. | |
+13,45% | 219 mld. | |
+6,04% | 199 mld. | |
-10,51% | 196 mld. | |
-12,26% | 149 mld. | |
-6,47% | 146 mld. |